181 – 190 of 300
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
(
- Contribution to journal › Article
-
Mark
Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice
(
- Contribution to journal › Article
-
Mark
Therapeutic hypothermia for comatose survivors after near-hanging-A retrospective analysis
(
- Contribution to journal › Article
-
Mark
Naturalistic studies - Researching the everyday clinical world
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors
2009) In Proceedings of the National Academy of Sciences of the United States of America 106(47). p.6-19801(
- Contribution to journal › Article
-
Mark
The parametric response map is an imaging biomarker for early cancer treatment outcome
(
- Contribution to journal › Article
- 2008
-
Mark
Standards of care for acute and chronic musculoskeletal pain: The bone and joint decade (2000-2010)
(
- Contribution to journal › Article
-
Mark
Gender differences in lumbar disc herniation surgery
(
- Contribution to journal › Article
-
Mark
Liposarcoma : outcome based on the Scandinavian Sarcoma Group register
(
- Contribution to journal › Article
-
Mark
The nitrone free radical scavenger NXY-059 is neuroprotective when administered after traumatic brain injury in the rat
(
- Contribution to journal › Article